Holen Sie sich die Stockscreener-App
2.64
7.69%
-0.22
Handel nachbörslich:
2.63
-0.01
-0.38%
Maravai Lifesciences Holdings Inc Aktie (MRVI) Neueste Nachrichten
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming DeadlinesMRVI - PR Newswire
NASDAQ: MRVI Lawsuit Alert: Investors with substantial losses from shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) purchased between Aug. 2024 and Feb. 2025 should contact the Shareholders Foundation - PR Newswire
Maravai Lifesciences stock hits 52-week low at $2.63 By Investing.com - Investing.com South Africa
Maravai Lifesciences stock hits 52-week low at $2.63 - Investing.com
Class Action Filed Against Maravai LifeSciences Holdings, Inc. (MRVI)May 5, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences - GlobeNewswire
Maravai LifeSciences Holdings, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before May 5, 2025 to Discuss Your RightsMRVI - ACCESS Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Maravai - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to ... - Bluefield Daily Telegraph
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
Class Action Filed Against Maravai LifeSciences Holdings, - GlobeNewswire
Law Offices of Frank R. Cruz Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors To Inquire About Securities Fraud Class Action - Business Wire
MRVI Investors Have Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
MRVI INVESTOR DEADLINE: Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
MRVI LAWSUIT ALERT: The Gross Law Firm Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - PR Newswire
MRVI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Maravai LifeSciences Holdings, Inc. (MRVI): Why Are Hedge Funds Bullish On This Cash-Rich Penny Stock? - Insider Monkey
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences - GlobeNewswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences - GlobeNewswire Inc.
Maravai LifeSciences Holdings, Inc. Shareholder Notice: - GlobeNewswire
NASDADQ: MRVI Investor Reminder: Kessler Topaz Meltzer & - GlobeNewswire
Maravai LifeSciences Holdings, Inc. Shareholder Notice: Robbins LLP Reminds Investors of the ... - Bluefield Daily Telegraph
MRVI INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
Maravai LifeSciences Holdings, Inc. Sued for Securities Law - GlobeNewswire
DEADLINE ALERT for SWKS, MRVI, and APP: The Law Offices of - GlobeNewswire
MRVI Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Maravai LifeSciences Holdings, Inc. (MRVI)Contact Kessler Topaz Meltzer & Check, LLP - Business Wire
Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Clas - GuruFocus.com
Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue RecognitionHagens Berman - PR Newswire
MRVI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Maravai LifeSciences Holdings, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
MRVI LAWSUIT ALERT: Levi & Korsinsky Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - PR Newswire
Rhumbline Advisers Buys 16,712 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI) - Defense World
NASDADQ: MRVI Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Class Action Lawsuit Against Maravai LifeSciences Holdings, Inc. (MRVI) - PR Newswire
Lost Money on Maravai LifeSciences Holdings, Inc.(MRVI)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - ACCESS Newswire
12 Cash-Rich Penny Stocks To Buy According To Hedge Funds - Insider Monkey
Deadline Alert: Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - Business Wire
MRVI INVESTOR ALERT: Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
MRVI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Maravai LifeSciences Holdings, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Y Intercept Hong Kong Ltd Increases Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Investor Alert: Robbins LLP Informs Investors of the Maravai LifeSciences Holdings, Inc. Class Action Lawsuit - PR Newswire
MARAVAI ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire
MRVI ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Maravai Lifesciences Holdings, Inc. Investors - Business Wire
Maravai LifeSciences (NASDAQ:MRVI) Sets New 52-Week Low After Analyst Downgrade - Defense World
Biotech Co. Maravai Hit With Investor's Internal Controls Suit - Law360
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Inquire about Securities Investigation - Markets Insider
MRVI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Maravai LifeSciences Holdings, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities - GlobeNewswire
Rosen Law Firm Urges Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) Stockholders to Contact the Firm for Information About Their Rights - Joplin Globe
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP - GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of - The Bakersfield Californian
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences | FinancialContent - Financial Content
The Law Offices of Frank R. Cruz Files Lawsuit Against Maravai LifeSciences Holdings, Inc. - Lawyer Monthly Magazine
Maravai LifeSciences Delays 2024 Annual Report Filing - TipRanks
MRVI INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Maravai Lifesciences Holdings Inc Files For Non-Timely 10-K With The U.S. SEC - TradingView
MRVI CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Maravai LifeSciences Holdings, Inc. - Business Wire
MRVI LAWSUIT: Maravai LifeSciences Holdings Inc. Sued For - GlobeNewswire
MRVI LAWSUIT: Maravai LifeSciences Holdings Inc. Sued For Securities Fraud; Investors Should - The Bakersfield Californian
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences - Business Wire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Reach Out - Markets Insider
Maravai Lifesciences stock hits 52-week low at $2.93 - Investing.com
MRVI INVESTIGATION: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
2.14%
2.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):